Medicinal Plants and Zinc: Impact on COVID-19 Pandemic
- PMID: 34602868
- PMCID: PMC8483924
- DOI: 10.1155/2021/9632034
Medicinal Plants and Zinc: Impact on COVID-19 Pandemic
Abstract
The world is currently grappling with the coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The infection can cause fever, a dry cough, fatigue, severe pneumonia, respiratory distress syndrome, and in some cases death. There is currently no effective antiviral SARS-CoV-2 drug. To reduce the number of infections and deaths, it is critical to focus on strengthening immunity. This review aims to conduct a comprehensive search on the previous studies using Google Scholar, ScienceDirect, Medline, PubMed, and Scopus for the collection of research papers based on the role of zinc in the immune system, the antiviral activity of zinc, the effect of zinc supplementation in respiratory infections, the therapeutic approaches against viral infections based on medicinal plants, and the role of plants' bioactive molecules in fighting viral infections. In conclusion, we highlighted the pivotal role of zinc in antiviral immunity and we suggested the bioactive molecules derived from medicinal plants as a search matrix for the development of anti-SARS-CoV-2 drugs.
Copyright © 2021 Zineb Jalal et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.Curr Pharm Biotechnol. 2021;22(4):444-450. doi: 10.2174/1389201021666200703201458. Curr Pharm Biotechnol. 2021. PMID: 32619167 Review.
-
Exploration of medicinal plants as potential therapeutics against COVID-19: molecular insights and drug development prospects with other significant medicinal information a retrospective exposition.J Pharm Pharmacol. 2025 Jan 6;77(1):18-31. doi: 10.1093/jpp/rgae074. J Pharm Pharmacol. 2025. PMID: 39173011
-
Systematic Review on Major Antiviral Phytocompounds from Common Medicinal Plants against SARS-CoV-2.Med Chem. 2024;20(6):613-629. doi: 10.2174/0115734064262843231120051452. Med Chem. 2024. PMID: 38317467
-
Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.Curr Pharm Des. 2021 Oct 5;27(31):3389-3398. doi: 10.2174/1381612827666210705163807. Curr Pharm Des. 2021. PMID: 34225610
-
Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.Molecules. 2021 Mar 22;26(6):1775. doi: 10.3390/molecules26061775. Molecules. 2021. PMID: 33809963 Free PMC article. Review.
Cited by
-
Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature.Molecules. 2022 Apr 25;27(9):2750. doi: 10.3390/molecules27092750. Molecules. 2022. PMID: 35566101 Free PMC article. Review.
-
The effect of Ni gella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial.Front Pharmacol. 2022 Nov 8;13:1011522. doi: 10.3389/fphar.2022.1011522. eCollection 2022. Front Pharmacol. 2022. PMID: 36425571 Free PMC article.
-
Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19.Heliyon. 2022 Sep 20;8(9):e10702. doi: 10.1016/j.heliyon.2022.e10702. eCollection 2022 Sep. Heliyon. 2022. PMID: 36157310 Free PMC article. Review.
-
Effect of zinc versus vitamin A supplementation on pediatric patients with community-acquired pneumonia.Front Pharmacol. 2022 Aug 30;13:933998. doi: 10.3389/fphar.2022.933998. eCollection 2022. Front Pharmacol. 2022. PMID: 36110532 Free PMC article.
-
Development of Therapeutic and Prophylactic Zinc Compositions for Use against COVID-19: A Glimpse of the Trends, Inventions, and Patents.Nutrients. 2022 Mar 14;14(6):1227. doi: 10.3390/nu14061227. Nutrients. 2022. PMID: 35334884 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous